美托洛尔治疗风湿性心脏病40例临床评价

目的观察美托洛尔对风湿性心脏病的，临床疗效。方法选取医院2013年6月至2015年6月收治的风湿性心脏病患者80例，随机分为2组。对照组采用常规治疗，观察组采用美托洛尔治疗，比较分析2组疗效和不良反应发生情况。结果观察组总有效率为97．50％，对照组为77．50％，差异有统计学意义（P〈0．05）；对照纽不良反应发生率为24．44％，观察组为11．11％，差异有统计学意义（P〈0．05）。观察组各项指标改善程度均高于对照组（P〈0．05）。结论美托洛尔治疗风湿性心脏病，能显著提高疗效，促进患者身体恢复．且安全性较高．有临床推广价值．

Objective To analyze the clinical effect of metoprolol in treatment of rheumatic heart disease.Methods Selected in our hospital in June 2013 to 2015 June were rheumatic heart disease patients with 80 cases as the object of study,and were di- vided for 2 groups.Patients in control group were treated with routine treatment,the observation group with metoprolol treatment, the comparative analysis of curative effect and adverse reactions of the two groups the incidence.Results The total effective rate in the observation group was 77.50% ,the control group was 97.50% ,the difference was statistically significant;the adverse reaction rate was 24.44% in the control group,the adverse reaction rate was ll.ll%,the difference was statistically significant.The im- provement in the observation group was higher than that in the control group.Conclusion Metoprolol in the treatment of rheumatic heart disease patients,can significantly improve the curative effect,improve the safety of the treatment,promote the re- covery of the patient＇s body,worthy of clinical promotion.